Journal
BIOMATERIALS
Volume 32, Issue 26, Pages 6194-6203Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2011.04.053
Keywords
Nanoparticle; Copolymer; Gene therapy; Phospholipid; Drug delivery; Controlled drug release
Funding
- NHLBI NIH HHS [R01 HL085416-04, R01 HL085416-03, R01 HL085416, R01 HL085416-05, R01 HL085416-03W1] Funding Source: Medline
- NIBIB NIH HHS [R01 EB000487-18A2, R01 EB000487, R01 EB000487-21, R01 EB000487-20, R01 EB000487-19] Funding Source: Medline
- NIDDK NIH HHS [T90 DK070068-05, T90 DK070068-04, T90 DK070068] Funding Source: Medline
Ask authors/readers for more resources
We have developed a polymer nanoparticle-based siRNA delivery system that exploits a cell surface binding synergism between targeting ligands and cell-penetrating peptides. Nanoparticles were coated with folate and penetratin via a PEGylated phospholipid linker (DSPE-PEG): the combination of both of these ligands represents a strategy for enhancing intracellular delivery of attached polymer nanoparticles. Nanoparticles were characterized for size, morphology, density of surface modification, and ligand association and retention. The surface coverage achieved on DSPE-PEG-coated nanoparticles is as high as (or higher than) obtained with other ligand-modified nano-scale particulate systems (similar to 0.5-5 pmol ligand/cm(2)). Additionally, these nanoparticles were loaded with a high density of siRNA (similar to 130-140 pmol siRNA/mg nanoparticles), which is slowly released upon incubation in water. Synergies between the activity of surface binding and cell internalizing ligands on these siRNA-loaded nanoparticles impart delivery enhancements that improve their gene silencing efficacy both in culture and in tumor models. Traditionally, targeting ligands function by binding to cell surface receptors, while cell-penetrating peptides function by nonspecifically transporting across cell membranes. Interestingly, we have observed that improved delivery of these dual-functionalized nanoparticles was in part, a result of increased cell surface avidity afforded by both ligands. This siRNA delivery system presents an approach to surface modification of nanovehicles, in which multiple ligands function in parallel to enhance cell binding and uptake. (C) 2011 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available